GenLumina
PrivateLast Round
Seed
Jun 17, 2025
Est. Valuation
$10.9M
Total Funding Raised
$640,000
Company Overview
GenLumina is a biotechnology company developing a light-activated DNA nanomedicine platform for targeted oncology treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenLumina Comparables
Compare GenLumina with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DoriNano | 82% | |
| Light Switch Bio | 81% | |
| Illuminate Therapeutics | 81% |
GenLumina Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 17, 2025 | ||||
| Early Funding | Jun 13, 2025 | ||||
| Grant | Nov 6, 2024 | ||||
| Pre Seed | Aug 13, 2024 |
GenLumina Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Libertatis Ergo Holding | Pre Seed |
| InnovationQuarter | Seed |
GenLumina Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GenLumina's valuation, stock price, and market status.
Is GenLumina a public or private company?
GenLumina is a private company.
What is the current stock price of GenLumina?
GenLumina is a private company with no public stock price. Caplight tracks GenLumina's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is GenLumina worth (valuation)?
GenLumina's valuation is estimated at $10.9M based on funding round data.
Can I buy GenLumina stock?
GenLumina shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GenLumina's last funding round?
GenLumina's most recent funding round was Seed on June 13, 2025.
Who are the main investors in GenLumina?
Key investors in GenLumina include InnovationQuarter.
Will GenLumina IPO soon?
No public IPO plans have been announced for GenLumina.
How can I track GenLumina secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GenLumina's secondary market activity and sign up for updates.